Skip to main content

Table 2 Clinical manifestations of patients with Behçhet's disease in relation to anti-Sip1 C-ter autoantibodies

From: Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease

Clinical manifestation of the 56 patients with Behçet's disease

Number of total samples (%)

Anti-Sip1 C-ter antibody response, number of positive samples (%)

  

IgG

IgM

IgA

Skin lesions

36 (64)

7 (19)

14 (39)

7 (19)

Ocular inflammation

38 (68)

8 (21)

16 (42)

5 (13)

Genital aphtosis

27 (48)

5 (18)

8 (29)

5 (18)

Arthritis

10 (18)

1 (10)

6 (60)

2 (20)

Vascular manifestations

10 (18)

4 (40)

6 (60)

4 (40)

Neurological manifestations

6 (11)

0

1 (1.6)

0

  1. Sip1 C-ter, carboxy-terminal subunit of Sip1.